Jesduvroq (daprodustat) is a medication that was approved by the FDA in February 2023 treat anemia in adults who are receiving dialysis. It's taken by mouth once a day. This is more convenient in comparison to erythropoiesis-stimulating agents (ESAs), which needs to be injected. Jesduvroq (daprodustat) can cause serious side effects, including heart attack and stroke. Before starting treatment, tell your provider about your medical history so they can make sure this medication is safe for you.
Anemia due to chronic kidney disease (CKD) in adults who've been on dialysis for at least 4 months
Jesduvroq (daprodustat) is a hypoxia-inducible factor–prolyl hydroxylase (HIF-PH) inhibitor. It helps prevent your body from breaking down HIF, a protein that responds to low oxygen. HIF triggers the production of different hormones, including erythropoietin (EPO), which sends a signal to your body to make more red blood cells. This helps to treat anemia and ultimately avoid the need for blood transfusions.
Source:Â DailyMed
Taken once a day
Taken by mouth, so it's more convenient than ESAs that need to be injected
The first medication of its class, so it might work for people with CKD on dialysis who didn’t see benefits with other medications for anemia
Not safe for use while pregnant or breastfeeding
Interacts with some medications, including gemfibrozil (Lopid) and clopidogrel (Plavix)
Raises the risk of heart attack and stroke
You can take Jesduvroq (daprodustat) with or without food, but swallow the tablets whole. Don't crush, chew, or cut the tablets because this can change the way the medication works for you.
Talk to your provider if you have a history of heart or blood clotting problems. Jesduvroq (daprodustat) can raise your risk of blood clots and might make you more prone to heart attacks or stroke. Get medical help right away if you experience any symptoms of blood clots, including chest pain, breathing problems, or sudden weakness or confusion.
Jesduvroq (daprodustat) can raise your blood pressure, sometimes to dangerous levels. Your provider will need to check your blood pressure regularly before and during treatment to make sure this medication is safe for you. If you have a history of high blood pressure, make sure to take your blood pressure medications as prescribed to keep it under control.
Before starting Jesduvroq (daprodustat), you'll need to get blood work done to check your liver health, iron levels, and blood cell counts. Make sure you get routine blood tests done on time while you're taking this medication. Your provider might need to adjust your dose of Jesduvroq (daprodustat) based on the results of your lab work to prevent serious side effects, such as blood clots. By getting regular blood tests done, your provider can continue to make sure Jesduvroq (daprodustat) is working and is safe for you.
Jesduvroq (daprodustat) can interact with many medications. For example, you won't be able to take medications such as gemfibrozil (Lopid), during treatment with Jesduvroq (daprodustat). Doing so can cause the body to absorb more of this medication, causing greater risk of side effects. Let your provider or pharmacist know what medications you're taking, including over-the-counter products and supplements, before you start Jesduvroq (daprodustat).
If you accidentally took more than your prescribed dose of Jesduvroq (daprodustat), or you experience symptoms of severe headache or nausea, get medical attention right away. These might be signs of serious side effect, such as dangerously high blood pressure or a blood clot.
Jesduvroq (daprodustat) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Heart attack or stroke in the past 3 months | Hemoglobin levels rising too quickly | Hemoglobin levels greater than 11 g/dL
Jesduvroq (daprodustat) can cause serious blood clot problems (e.g., heart attack and stroke), which can be life-threatening. The risk is higher if you have a history of heart conditions, blood vessel problems, or if you have higher levels of hemoglobin. You won't be able to take this medication if you had an episode of a blood clot in the last 3 months, such as a heart attack or stroke. Blood clots can form in places like your legs, lungs, heart, or brain. To lower your risk of serious clots, your provider will work with you to find the lowest dose of Jesduvroq (daprodustat) that helps you avoid blood transfusions.
Get medical help right away if you experience any symptoms of blood clots:
Risk factor: History of heart failure
Jesduvroq (daprodustat) might worsen symptoms of heart failure. Your risk is higher if you have a history of heart failure. In some cases, people have had to go to the hospital for their heart failure after taking this medication. Tell your provider right away if you have symptoms of heart failure, such as trouble breathing, cough, wheezing, swelling, or tiredness.
Risk factor: High blood pressure that's not well-controlled
Jesduvroq (daprodustat) can raise your blood pressure, sometimes to dangerous levels. As a result, this medication isn't recommended for you if your blood pressure isn't well-controlled. To make sure this medication is safe for you, your provider will check your blood pressure regularly while you take Jesduvroq (daprodustat). Sometimes, your provider might prescribe you or adjust your dose of blood pressure medications to better control your blood pressure. If you experience symptoms of dangerously high blood pressure, such as headache, nausea, vomiting, confusion, blurry vision, or seizures, get medical help right away.
Risk factors: smoking tobacco | Drinking alcohol| Taking medications that cause stomach problems | History of stomach problems
Jesduvroq (daprodustat) can sometimes damage the lining of the stomach and lead to problems, such as stomach bleeding or sores. The risk is higher if you take medications that can irritate the stomach (e.g., ibuprofen (Advil), naproxen), or if you have a history of stomach problems (e.g., heartburn, stomach ulcers). Let your provider know right away if you have signs or symptoms of stomach problems, such as dark stool, blood in the urine, or coffee-ground vomit.
Risk factor: History of cancer
Based on the way Jesduvroq (daprodustat) works, there's a possible risk that it can cause cancer cells to grow. The safety of Jesduvroq (daprodustat) haven't been studied in people who have cancer. If you're currently being treated for cancer or if you have a history of cancer, let your provider know. Your provider will likely recommend that you don't take this medication.
Adults not taking an erythropoiesis stimulating agent (ESA)
Your provider will determine your dose of Jesduvroq (daprodustat) based on your hemoglobin level. The typical starting dose is 1 mg to 4 mg by mouth once daily. Your provider might change your dose every 2 or 4 weeks, depending on your hemoglobin level. The maximum daily dose is 24 mg daily.
Adults switching from an ESA
Your provider will determine your dose of Jesduvroq (daprodustat) based on what ESA you're taking and the dose of your ESA. The typical starting dose of Jesduvroq (daprodustat) is 4 mg to 12 mg by mouth once daily. Your provider might change your dose every 2 or 4 weeks, depending on your hemoglobin level. The maximum daily dose is 24 mg daily.
Your dose of Jesduvroq (daprodustat) might be different if you have liver problems or if you're taking certain medications that might interact with Jesduvroq (daprodustat).
Taking certain medications, such as gemfibrozil (Lopid)
Uncontrolled high blood pressure
Anemia due to chronic kidney disease (CKD) in adults who've been on dialysis for at least 4 months
Treatment of anemia due to chemotherapy, chronic kidney disease, and zidovudine use in HIV-infected patients
Reduction of allogeneic red blood cell transfusions in patients having elective, noncardiac, nonvascular surgery
Anemia due to chemotherapy
Anemia due to chronic kidney disease (dialysis and non-dialysis)
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
American Heart Association. (2023). Heart failure signs and symptoms.
Becker, K. A., et al. (2018). An emerging treatment alternative for anemia in chronic kidney disease patients: A review of daprodustat. Advances in Therapy.
Billett, H. H., et al. (1990). Chapter 151: Hemoglobin and hematocrit. Clinical Methods: The History, Physical, and Laboratory Examinations, 3rd edition.
Centers for Disease Control and Prevention. (2023). Know the risks, signs & symptoms of blood clots.
GlaxoSmithKline LLC. (2023). Jesduvroq- daprodustat tablet, film coated [package insert]. DailyMed.
MedlinePlus. (2022). Hemoglobin test.
National Kidney Foundation. (2015). Hemodialysis access.
Singh, A. K., et al. (2021). Daprodustat for the treatment of anemia in patients undergoing dialysis. The New England Journal of Medicine.
U.S. Food and Drug Administration. (2023). FDA approves first oral treatment for anemia caused by chronic kidney disease for adults on dialysis.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.